Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Wai Chun Bio-TechnologyHKSE:00660 23 FCF Margin % is 6.36% as of Dec. 2025. GuruFocus rates HKSE:00660 with a GF Score™ of 23/100. The stock has 6 warning signs investors should review. Among 1,578 Chemicals companies, Wai Chun Bio-Technology ranks better than 59.38% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Wai Chun Bio-Technology's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wai Chun Bio-Technology FCF Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Wai Chun Bio-Technology's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Wai Chun Bio-Technology's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wai Chun Bio-Technology (HKSE:00660) has a FCF Margin % of 6.36% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Wai Chun Bio-Technology and its competitors. According to the industry distribution chart, Wai Chun Bio-Technology ranks #641 out of 1578 companies in the Chemicals industry, placing it in the top 40.6%.
Is Wai Chun Bio-Technology's FCF Margin % too high?
Wai Chun Bio-Technology's current FCF Margin % is 6.36%. The Chemicals industry median FCF Margin % is 2.06. Wai Chun Bio-Technology's value of 6.36% is 209.5% above this industry median. Based on the distribution chart, Wai Chun Bio-Technology ranks #641 out of 1578 companies in the Chemicals industry, which is above the industry midpoint. Overall, Wai Chun Bio-Technology has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Wai Chun Bio-Technology's FCF Margin % compare to DOW?
According to the Chemicals industry distribution chart, Wai Chun Bio-Technology ranks #641 out of 1578 companies for FCF Margin %. This puts Wai Chun Bio-Technology in the upper half of its industry. The industry median FCF Margin % is 2.06. Wai Chun Bio-Technology's value of 6.36% is 209.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Chemicals company?
The median FCF Margin % among Chemicals companies is 2.06, based on 1,578 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wai Chun Bio-Technology's current FCF Margin % of 6.36% is 209.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Wai Chun Bio-Technology and its competitors. For the Chemicals industry, the median FCF Margin % is 2.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wai Chun Bio-Technology's current FCF Margin % is 6.36%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wai Chun Bio-Technology stock overvalued right now?
Wai Chun Bio-Technology (HKSE:00660) has a current FCF Margin % of 6.36%. The current FCF Margin % is 6.36% and 209.5% above the Chemicals industry median of 2.06. Wai Chun Bio-Technology's overall GF Score™ is 23/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Wai Chun Bio-Technology (HKSE:00660), the current FCF Margin % is 6.36% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Wai Chun Bio-Technology Ltd is an investment holding company. The company has one reportable segmentbeing the manufacturing and sale of modified starch and other biochemical products. It is involved in the manufacturing and sale of modified starch and other biochemical products. Geographically, it derives a majority of its revenue from the People's Republic of China. The company also has its presence in Hong Kong.
23GF Score
Get the complete analysis for HKSE:00660
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00660 has been successfully added to your 
